Passage Bio Inc (NASDAQ:PASG)’s traded shares stood at 0.19 million during the last session, with the company’s beta value hitting 1.29. At the close of trading, the stock’s price was $1.35, to imply an increase of 3.05% or $0.04 in intraday trading. The PASG share’s 52-week high remains $1.79, putting it -32.59% down since that peak but still an impressive 57.04% since price per share fell to its 52-week low of $0.58. The company has a valuation of $75.06M, with an average of 0.87 million shares in intraday trading volume over the past 10 days and average of 429.80K shares over the past 3 months.
Passage Bio Inc (NASDAQ:PASG) trade information
After registering a 3.05% upside in the last session, Passage Bio Inc (PASG) has traded red over the past five days. The stock hit a weekly high of 1.4219, jumping 3.05% in its intraday price action. The 5-day price performance for the stock is -1.46%, and -21.97% over 30 days. With these gigs, the year-to-date price performance is 33.66%. Short interest in Passage Bio Inc (NASDAQ:PASG) saw shorts transact 1.21 million shares and set a 3.16 days time to cover.
Passage Bio Inc (PASG) estimates and forecasts
Looking at statistics comparing Passage Bio Inc share performance against respective industry, we note that the company has outperformed competitors. Passage Bio Inc (PASG) shares are 103.19% up over the last 6 months, with its year-to-date growth rate higher than industry average at 31.72% against 12.70%. Revenue is forecast to grow 42.90% this quarter before jumping 18.20% for the next one.
PASG Dividends
Passage Bio Inc has its next earnings report out between May 09 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Passage Bio Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Passage Bio Inc (NASDAQ:PASG)’s Major holders
Passage Bio Inc insiders hold 0.35% of total outstanding shares, with institutional holders owning 54.09% of the shares at 54.29% float percentage. In total, 54.09% institutions holds shares in the company, led by Orbimed Advisors LLC.. As of Jun 29, 2023, the company held over 10.12 million shares (or 18.47% of shares), all amounting to roughly $9.53 million.
The next major institution holding the largest number of shares is Versant Venture Management, LLC with 4.96 million shares, or about 9.05% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $4.67 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Passage Bio Inc (PASG) shares. Going by data provided on Jun 29, 2023, Vanguard Total Stock Market Index Fund holds roughly 1.5 million shares. This is just over 2.73% of the total shares, with a market valuation of $1.41 million. Data from the same date shows that the other fund manager holds a little less at 0.44 million, or 0.80% of the shares, all valued at about 0.41 million.
